-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B7PxIOkZQLkxMoMZOFksJNEtb66fKF6BavBCvSWKPvqBkU8f3n56QVPZJzuIxU3y ZRH0JvSkx6oZpNXZ8YY+rA== 0001209191-05-024453.txt : 20050506 0001209191-05-024453.hdr.sgml : 20050506 20050506170340 ACCESSION NUMBER: 0001209191-05-024453 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050504 FILED AS OF DATE: 20050506 DATE AS OF CHANGE: 20050506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOX BARRY M CENTRAL INDEX KEY: 0001206376 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 05808817 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY STREET STREET 2: C/O GUILFORD PHARMACEUTICALS INC CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 MAIL ADDRESS: STREET 1: C/O GUILFORD PHARMACEUTICALS INC STREET 2: 6611 TIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-05-04 0 0000918066 GUILFORD PHARMACEUTICALS INC GLFD 0001206376 FOX BARRY M C/O GUILFORD PHARMACEUTICALS 6611 TRIBUTARY ST. BALTIMORE MD 21224 1 0 0 0 Restricted Stock Units 0.00 Common Stock 2609 10008 D Stock Options (Right to buy) 2.47 2005-05-04 4 A 0 7500 2.47 A 2006-05-04 2015-05-04 Common Stock 7500 7500 D Stock Options (Right to buy) 4.20 2003-09-20 2012-09-20 Common Stock 30000 30000 D Stock Options (Right to buy) 6.38 2005-05-05 2014-05-05 Common Stock 7500 7500 D The Restricted Stock Units will be exchanged for shares of the Company's common stock six months after termination of Mr. Fox's service with the Company's Board of Directors. The options to which this note relates will vest 50% on the first anniversary of the date of grant and 50% on the second anniversary of the date of grant. Asher M. Rubin, Attorney-in-fact 2005-05-06 -----END PRIVACY-ENHANCED MESSAGE-----